Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - adrenaline (epinephrine), quantity: 1 mg - injection, solution - excipient ingredients: tartaric acid; sodium metabisulfite; sodium chloride; water for injections; dilute hydrochloric acid; sodium hydroxide - an adjunct in the management of cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - adrenaline (epinephrine), quantity: 1 mg - injection, solution - excipient ingredients: tartaric acid; sodium metabisulfite; sodium chloride; water for injections - the drug of choice in the emergency treatment of acute severe anaphylactic reactions due to insect bites, drugs and other allergens. it may also be used for the symptomatic relief of respiratory distress due to bronchospasm.

Ireland - English - HPRA (Health Products Regulatory Authority)

dlrc pharma services limited - adrenaline - solution for injection - 0.1 milligram(s)/millilitre - adrenergic and dopaminergic agents; epinephrine

Ireland - English - HPRA (Health Products Regulatory Authority)

dlrc pharma services limited - adrenaline - solution for injection - 1 milligram(s)/millilitre - adrenergic and dopaminergic agents; epinephrine

Israel - English - Ministry of Health

a.l. medi-market ltd. - noradrenaline as tartrate - concentrate for solution for infusion - noradrenaline as tartrate 1 mg / 1 ml - norepinephrine - noradrenaline kalceks is indicated for blood pressure control in certain acute hypotensive states (e.g., pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infarction, septicemia, blood transfusion, and drug reactions). as an adjunct in the treatment of cardiac arrest and profound hypotension.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 4mg/4ml concentrate for solution for infusion ampoules (aguettant ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 8mg/8ml concentrate for solution for infusion ampoules (aguettant ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections; sodium hydroxide; sodium metabisulfite - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.12 mg/ml equivalent to 0.06mg/ml noradrenaline base;   - solution for infusion - 0.06 mg/ml - active: noradrenaline acid tartrate monohydrate 0.12 mg/ml equivalent to 0.06mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.159 g/l equivalent to 0.08 g/l noradrenaline base - solution for infusion - 0.08 mg/ml - active: noradrenaline acid tartrate monohydrate 0.159 g/l equivalent to 0.08 g/l noradrenaline base excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).